WMD WeedMD Inc

WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally licensed producer and distributor of medical-grade cannabis, is pleased to announce the debut of its strain-specific live resin product for release under its Color Cannabis adult-use brand, 510-thread vaporization carts. Products will be available for purchase from the Ontario Cannabis Store starting in May, 2021 with eventual expansion to additional provinces and retailers. The live resin line offered in Pedro’s Sweet Sativa cultivar is the first in a series of new extract products recently announced by the Company that will eventually expand to feature solventless hash and rosin concentrates.

WeedMD partnered with Ontario’s Peak Processing, a highly skilled, third-party processer that specializes in developing hydrocarbon extract of freshly harvested and frozen cannabis biomass to produce live resin formulations. This process ensures the cannabinoid and terpene-rich trichomes are preserved at harvest to produce some of the purest, true-to-nature forms of concentrates from the Company’s award-winning genetics.

“With the launch of our live resin products, we’re excited to introduce consumers to another authentic offering featuring the unique cultivar that is Pedro’s Sweet Sativa,” said Joseph Mele, Senior Vice President, Commercial Sales and Marketing, WeedMD. “The goal with all Color Cannabis products is to expand consumers' awareness - particularly for those seeking unique terpene profiles and new premium, high-value concentrates. Peak Processing has carefully extracted live resin from fresh-frozen Pedro’s Sweet Sativa, grown and processed alongside our skilled teams, and we’re looking forward to adding more cultivars to this innovative line up.”

WeedMD is expected to release additional Cannabis 2.0 extract products including solventless hash and rosin concentrates throughout 2021, under its Color Cannabis and Saturday Cannabis adult-use brands. Product development for both solventless cannabis concentrates, including bubble hash and rosin extract products, is currently underway alongside WeedMD and its highly skilled third-party processors currently undergoing trialing processes.

The Company has further developed a unique, in-house sub-critical CO2 extract post-processing methodology, which preserves the flower’s terpene profile and results in a malleable, semi-solid high-potency cannabis extract product. Trials to confirm scalability and product integrity are also currently underway at the Company’s Aylmer, Ontario processing and extraction hub.

Extract products will be produced using WeedMD’s own biomass, grown on site at the Company’s state-of-the-art greenhouse and outdoor field in Strathroy, Ontario.

Access WeedMD’s 2021 Shareholder Newsletter here. Information about upcoming corporate events can be found here.

About WeedMD Inc.

WeedMD Inc. is the publicly traded parent company of WeedMD RX Inc. and Starseed Medicinal Inc., licence holders producing and distributing cannabis products for both the medical and adult-use markets. The Company owns and operates a 158-acre state-of-the-art greenhouse, outdoor and processing facility located in Strathroy, ON as well as a fully-licensed 26,000 sq. ft. Aylmer, ON processing facility, specializing in cannabis extraction. With the addition of Starseed, a medical-centric operator, WeedMD has expanded its multi-channeled distribution strategy. Starseed’s industry-first, exclusive partnership with LiUNA, the largest construction union in Canada, along with employers and union groups complements WeedMD’s direct sales to medical patients. The Company maintains strategic relationships in the seniors’ market and supply agreements with Shoppers Drug Mart as well, as seven provincial distribution agencies where adult-use brands Color Cannabis and Saturday are sold.

Follow WeedMD on LinkedIn

Twitter: WeedMD, Color Cannabis, Saturday Cannabis & Starseed

Instagram: WeedMD, Color Cannabis, Saturday Cannabis & Starseed                                                              

For further information, please contact:

For Investor Enquiries:Valter PintoManaging Director KCSA Strategic Communications1-212-896-1254weedmd@kcsa.com

For Media Enquiries:Marianella delaBarreraVP, Communications & Corporate Affairs416-897-6644marianella@weedmd.com

To learn more, visit us at www.weedmd.com

All product images and labels are provided for information and illustrative purposes only, and do not represent the actual cannabis product, product label, or its appearance.

Forward Looking Information This press release contains "forward-looking information" within the meaning of applicable Canadian securities legislation which are based upon WeedMD's current internal expectations, estimates, projections, assumptions and beliefs and views of future events. Forward-looking information can be identified by the use of forward-looking terminology such as "expect", "likely", "may", "will", "should", "intend", "anticipate", "potential", "proposed", "estimate" and other similar words, including negative and grammatical variations thereof, or statements that certain events or conditions "may", "would" or "will" happen, or by discussions of strategy.

The forward-looking information in this news release is based upon the expectations, estimates, projections, assumptions and views of future events which management believes to be reasonable in the circumstances. Forward-looking information includes estimates, plans, expectations, opinions, forecasts, projections, targets, guidance or other statements that are not statements of fact. Forward-looking information in this news release include, but are not limited to, statements with respect to internal expectations, expectations with respect to actual production volumes, expectations for future growing capacity and the completion of any capital project or expansions. Forward-looking information necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; loss of markets; future legislative and regulatory developments; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; the cannabis industry in Canada generally; the ability of WeedMD to implement its business strategies; the COVID-19 pandemic; competition; crop failure; and other risks.

Any forward-looking information speaks only as of the date on which it is made, and, except as required by law, WeedMD does not undertake any obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise. New factors emerge from time to time, and it is not possible for WeedMD to predict all such factors. When considering this forward-looking information, readers should keep in mind the risk factors and other cautionary statements in WeedMD's disclosure documents filed with the applicable Canadian securities regulatory authorities on SEDAR at www.sedar.com. The risk factors and other factors noted in the disclosure documents could cause actual events or results to differ materially from those described in any forward-looking information.

NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/f6efef63-87e0-4886-b305-826f7812910a